Can-Fite BioPharma Ltd. SEC filings CANF

Can-Fite BioPharma Ltd. has 865 filings in SEC EDGAR's recent list, going back to Dec 1, 2011. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.

Can-Fite BioPharma Ltd. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 2, 2026 Nov 2, 2026
6-K Current report (foreign issuer) Oct 26, 2026 Oct 26, 2026
EFFECT Filing Oct 9, 2026 —
EFFECT Filing Oct 9, 2026 —
424B3 Prospectus Oct 9, 2026 —
F-3 Shelf registration (foreign issuer) Sep 25, 2026 —
F-3/A Amendment no. 1 to form f-3 Sep 25, 2026 —
EFFECT Filing Sep 11, 2026 —
EFFECT Filing Sep 11, 2026 —
D Filing Sep 10, 2026 —
6-K Current report (foreign issuer) Sep 9, 2026 Sep 9, 2026
POS AM Post-effective amendment no. 11 to form f-1 Sep 8, 2026 —
POS AM Post-effective amendment no. 11 to form f-1 Sep 8, 2026 —
6-K Current report (foreign issuer) Sep 8, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Sep 3, 2026 Sep 3, 2026
6-K Current report (foreign issuer) Sep 2, 2026 Sep 2, 2026
6-K Current report (foreign issuer) Sep 2, 2026 Sep 2, 2026
F-3 Shelf registration (foreign issuer) Aug 28, 2026 —
6-K Current report (foreign issuer) Aug 17, 2026 Aug 17, 2026
6-K Current report (foreign issuer) Aug 12, 2026 Aug 12, 2026
6-K Current report (foreign issuer) Aug 3, 2026 Aug 3, 2026
6-K Current report (foreign issuer) Jul 20, 2026 Jul 20, 2026
6-K Current report (foreign issuer) Jul 14, 2026 Jul 14, 2026
6-K Current report (foreign issuer) Jul 6, 2026 Jul 6, 2026
6-K Current report (foreign issuer) Jul 1, 2026 Jul 1, 2026
6-K Current report (foreign issuer) Jun 26, 2026 Jun 26, 2026
6-K Current report (foreign issuer) Jun 22, 2026 Jun 22, 2026
6-K Current report (foreign issuer) Jun 17, 2026 Jun 17, 2026
6-K Current report (foreign issuer) Jun 4, 2026 Jun 4, 2026
6-K Current report (foreign issuer) Jun 2, 2026 Jun 2, 2026
6-K Current report (foreign issuer) May 28, 2026 May 28, 2026
6-K Current report (foreign issuer) May 18, 2026 May 18, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
6-K Current report (foreign issuer) Apr 30, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Apr 23, 2026 Apr 23, 2026
EFFECT Filing Apr 3, 2026 —
424B3 Prospectus Apr 3, 2026 —
CORRESP Letter to the SEC Apr 1, 2026 —
EFFECT Filing Mar 31, 2026 —
EFFECT Filing Mar 31, 2026 —
UPLOAD Letter from the SEC Mar 31, 2026 —
F-3 Shelf registration (foreign issuer) Mar 31, 2026 —
POS AM Post-effective amendment no. 9 to form f-1 Mar 31, 2026 —
POS AM Post-effective amendment no. 9 to form f-1 Mar 31, 2026 —
6-K Current report (foreign issuer) Mar 30, 2026 Mar 30, 2026
20-F Annual report (foreign issuer) Mar 26, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 26, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 17, 2026 Mar 17, 2026
6-K Current report (foreign issuer) Mar 10, 2026 Mar 10, 2026
424B3 Prospectus Mar 5, 2026 —
6-K Current report (foreign issuer) Mar 5, 2026 Mar 5, 2026
6-K Current report (foreign issuer) Mar 4, 2026 Mar 4, 2026
6-K Current report (foreign issuer) Mar 3, 2026 Mar 3, 2026
6-K Current report (foreign issuer) Feb 17, 2026 Feb 17, 2026
6-K Current report (foreign issuer) Feb 9, 2026 Feb 9, 2026
6-K Current report (foreign issuer) Feb 5, 2026 Feb 5, 2026
6-K Current report (foreign issuer) Jan 27, 2026 Jan 27, 2026
6-K Current report (foreign issuer) Jan 20, 2026 Jan 20, 2026
6-K Current report (foreign issuer) Jan 16, 2026 Jan 16, 2026
6-K Current report (foreign issuer) Dec 29, 2025 Dec 29, 2025
6-K Current report (foreign issuer) Dec 23, 2025 Dec 23, 2025
6-K Current report (foreign issuer) Dec 16, 2025 Dec 16, 2025
424B3 Prospectus Nov 21, 2025 —
6-K Current report (foreign issuer) Nov 21, 2025 Nov 21, 2025
6-K Current report (foreign issuer) Nov 20, 2025 Nov 20, 2025
6-K Current report (foreign issuer) Nov 18, 2025 Nov 18, 2025
6-K Current report (foreign issuer) Nov 10, 2025 Nov 10, 2025
6-K Current report (foreign issuer) Nov 3, 2025 Nov 3, 2025
6-K Current report (foreign issuer) Oct 3, 2025 Oct 3, 2025
6-K Current report (foreign issuer) Sep 15, 2025 Sep 15, 2025
EFFECT Filing Sep 11, 2025 —
EFFECT Filing Sep 11, 2025 —
POS AM Post-effective amendment no. 9 to form f-1 Sep 8, 2025 —
POS AM Post-effective amendment no. 9 to form f-1 Sep 8, 2025 —
POS AM Post-effective amendment no. 8 to form f-1 Sep 8, 2025 —
POS AM Post-effective amendment no. 8 to form f-1 Sep 8, 2025 —
POS AM Post-effective amendment no. 7 to form f-1 Aug 28, 2025 —
POS AM Post-effective amendment no. 7 to form f-1 Aug 28, 2025 —
6-K Current report (foreign issuer) Aug 28, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jul 30, 2025 Jul 30, 2025
424B4 Prospectus Jul 29, 2025 —
6-K Current report (foreign issuer) Jul 29, 2025 Jul 29, 2025
EFFECT Filing Jul 28, 2025 —
6-K Current report (foreign issuer) Jul 28, 2025 Jul 28, 2025
6-K Current report (foreign issuer) Jul 28, 2025 Jul 28, 2025
F-1/A Amendment no. 1 to form f-1 Jul 25, 2025 —
CORRESP Letter to the SEC Jul 24, 2025 —
CORRESP Letter to the SEC Jul 24, 2025 —
F-1 Registration statement (foreign issuer) Jul 23, 2025 —
UPLOAD Letter from the SEC Jul 22, 2025 —
CORRESP Letter to the SEC Jul 17, 2025 —
UPLOAD Letter from the SEC Jul 15, 2025 —
DRS Filing Jul 9, 2025 —
6-K Current report (foreign issuer) Jun 30, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jun 23, 2025 Jun 23, 2025
UPLOAD Letter from the SEC Jun 17, 2025 —
6-K Current report (foreign issuer) Jun 16, 2025 Jun 16, 2025
6-K Current report (foreign issuer) May 16, 2025 May 16, 2025
424B5 Prospectus supplement May 9, 2025 —
6-K Current report (foreign issuer) May 5, 2025 May 5, 2025
EFFECT Filing Apr 17, 2025 —
6-K Current report (foreign issuer) Apr 17, 2025 Apr 17, 2025
424B5 Prospectus supplement Apr 15, 2025 —
6-K Current report (foreign issuer) Apr 15, 2025 Apr 15, 2025
6-K Current report (foreign issuer) Apr 14, 2025 Apr 14, 2025
POS AM Post-effective amendment no. 8 to form f-1 Apr 14, 2025 —
6-K Current report (foreign issuer) Apr 14, 2025 Apr 14, 2025
6-K Current report (foreign issuer) Apr 14, 2025 Apr 14, 2025
20-F Annual report (foreign issuer) Apr 14, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 24, 2025 Mar 24, 2025
6-K Current report (foreign issuer) Mar 20, 2025 Mar 20, 2025
6-K Current report (foreign issuer) Mar 19, 2025 Mar 19, 2025
6-K Current report (foreign issuer) Mar 18, 2025 Mar 18, 2025
6-K Current report (foreign issuer) Mar 3, 2025 Mar 3, 2025
6-K Current report (foreign issuer) Feb 18, 2025 Feb 18, 2025
6-K Current report (foreign issuer) Feb 5, 2025 Feb 5, 2025
6-K Current report (foreign issuer) Jan 27, 2025 Jan 27, 2025
6-K Current report (foreign issuer) Dec 30, 2024 Dec 30, 2024
6-K Current report (foreign issuer) Dec 4, 2024 Dec 4, 2024
6-K Current report (foreign issuer) Nov 12, 2024 Nov 11, 2024
6-K Current report (foreign issuer) Nov 4, 2024 Nov 4, 2024
6-K Current report (foreign issuer) Oct 18, 2024 Oct 18, 2024
6-K Current report (foreign issuer) Oct 9, 2024 Oct 9, 2024
6-K Current report (foreign issuer) Sep 24, 2024 Sep 24, 2024
6-K Current report (foreign issuer) Sep 16, 2024 Sep 16, 2024
EFFECT Filing Sep 6, 2024 —
424B3 Prospectus Sep 6, 2024 —
CORRESP Letter to the SEC Sep 6, 2024 —
EFFECT Filing Sep 5, 2024 —
UPLOAD Letter from the SEC Sep 5, 2024 —
6-K Current report (foreign issuer) Aug 30, 2024 Aug 30, 2024
F-3 Shelf registration (foreign issuer) Aug 30, 2024 —
POS AM Post-effective amendment no. 7 to form f-1 Aug 30, 2024 —
424B5 Prospectus supplement Aug 30, 2024 —
6-K Current report (foreign issuer) Aug 29, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Aug 12, 2024 Aug 12, 2024
6-K Current report (foreign issuer) Aug 9, 2024 Aug 9, 2024
6-K Current report (foreign issuer) Jul 29, 2024 Jul 29, 2024
6-K Current report (foreign issuer) Jul 11, 2024 Jul 11, 2024
6-K Current report (foreign issuer) Jul 3, 2024 Jul 3, 2024
6-K Current report (foreign issuer) Jul 1, 2024 Jul 1, 2024
424B7 Prospectus supplement Jun 28, 2024 —
6-K Current report (foreign issuer) Jun 28, 2024 Jun 28, 2024
6-K Current report (foreign issuer) Jun 26, 2024 Jun 26, 2024
6-K Current report (foreign issuer) Jun 24, 2024 Jun 24, 2024
6-K Current report (foreign issuer) Jun 10, 2024 Jun 10, 2024
6-K/A Amendment no. 1 to form 6-k Jun 7, 2024 Jun 7, 2024
6-K Current report (foreign issuer) Jun 5, 2024 Jun 5, 2024
6-K Current report (foreign issuer) May 29, 2024 May 29, 2024
6-K Current report (foreign issuer) May 22, 2024 May 22, 2024
6-K Current report (foreign issuer) May 13, 2024 May 13, 2024
6-K Current report (foreign issuer) May 9, 2024 May 9, 2024
6-K Current report (foreign issuer) May 6, 2024 May 6, 2024
6-K Current report (foreign issuer) Apr 25, 2024 Apr 25, 2024
6-K Current report (foreign issuer) Apr 15, 2024 Apr 15, 2024
EFFECT Filing Apr 9, 2024 —
S-8 Employee stock plan registration Apr 5, 2024 —
POS AM Post-effective amendment no. 6 to form f-1 Apr 5, 2024 —
6-K Current report (foreign issuer) Apr 3, 2024 Apr 3, 2024
20-F Annual report (foreign issuer) Mar 28, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 28, 2024 Mar 28, 2024
6-K Current report (foreign issuer) Mar 11, 2024 Mar 11, 2024
6-K Current report (foreign issuer) Feb 28, 2024 Feb 28, 2024
6-K Current report (foreign issuer) Jan 30, 2024 Jan 30, 2024
6-K Current report (foreign issuer) Jan 29, 2024 Jan 29, 2024
EFFECT Filing Jan 5, 2024 —
CORRESP Letter to the SEC Jan 3, 2024 —
F-3/A Amendment no. 1 to form f-3 Dec 28, 2023 —
6-K Current report (foreign issuer) Dec 20, 2023 Dec 20, 2023
6-K Current report (foreign issuer) Dec 18, 2023 Dec 18, 2023
F-3 Shelf registration (foreign issuer) Dec 12, 2023 —
6-K Current report (foreign issuer) Dec 4, 2023 Dec 4, 2023
6-K Current report (foreign issuer) Nov 30, 2023 Nov 30, 2023
424B3 Prospectus Nov 22, 2023 —
6-K Current report (foreign issuer) Nov 22, 2023 Nov 22, 2023
6-K Current report (foreign issuer) Nov 21, 2023 Nov 21, 2023
6-K Current report (foreign issuer) Nov 21, 2023 Nov 21, 2023
6-K Current report (foreign issuer) Nov 1, 2023 Nov 1, 2023
6-K Current report (foreign issuer) Oct 30, 2023 Oct 30, 2023
6-K Current report (foreign issuer) Oct 26, 2023 Oct 26, 2023
6-K Current report (foreign issuer) Oct 10, 2023 Oct 10, 2023
6-K Current report (foreign issuer) Sep 27, 2023 Sep 27, 2023
EFFECT Filing Sep 12, 2023 —
CORRESP Letter to the SEC Sep 11, 2023 —
EFFECT Filing Sep 8, 2023 —
UPLOAD Letter from the SEC Sep 8, 2023 —
6-K Current report (foreign issuer) Sep 7, 2023 Sep 7, 2023
POS AM Post-effective amendment no. 5 to form f-1 Sep 1, 2023 —
F-3 Shelf registration (foreign issuer) Sep 1, 2023 —
6-K Current report (foreign issuer) Aug 31, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Aug 24, 2023 Aug 24, 2023
6-K Current report (foreign issuer) Aug 18, 2023 Aug 18, 2023
6-K Current report (foreign issuer) Aug 7, 2023 Aug 7, 2023
6-K Current report (foreign issuer) Jul 31, 2023 Jul 31, 2023
6-K Current report (foreign issuer) Jul 17, 2023 Jul 17, 2023
6-K Current report (foreign issuer) Jun 29, 2023 Jun 29, 2023
6-K Current report (foreign issuer) Jun 23, 2023 Jun 23, 2023
6-K Current report (foreign issuer) Jun 13, 2023 Jun 13, 2023
6-K Current report (foreign issuer) Jun 1, 2023 Jun 1, 2023
6-K Current report (foreign issuer) May 30, 2023 May 30, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CANF (NYSE)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ramat Gan, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1536196

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.